back to top
HomeTagsAcimtamig

Acimtamig

Affimed Broadcasts Optimistic Outcomes Demonstrating Security and Efficacy of Acimtamig and AlloNK ® Mixture in Relapsed/Refractory Classical Hodgkin Lymphoma (R/R cHL) Sufferers By Investing.com

The mixture of acimtamig with AlloNK ® demonstrated an total response charge of 86% and full response of 55% in 22 closely pretreated sufferers...

Most Popular

spot_img